Sterilant offers biological contamination solution
STERIS Corp., recently received market clearance from the Environmental Protection Agency (EPA) for expanded use of the company's Vaprox Hydrogen Peroxide Sterilant technology. The Vaprox/vaporized hydrogen peroxide system combination has been effective against bacterial spores, which are the most resistant forms of microorganisms found in the environment.
STERIS VHP sterilizers use a patented dry vapor sterilization method to inactivate biological contaminants. Vaprox is the first sterilant product of its kind to receive a registration for the sterilization of surfaces in large sealed enclosures. One of the VHP system's most revolutionary qualities is that it doesn't leave harmful surface residues, reducing to water vapor and oxygen at the end of the sterilization cycle.
New silver dressing seals wounds
Molnlycke Health Care US, LLC introduces Mepilex Ag, the first silver dressing with Safetac technology. This new product combines the excellent exudate management properties of Mepilex and Safetac's soft silicone adhesive technology with a powerful silver compound.
In vitro studies show that the Mepilex Ag dressing delivers sustained, effective release of silver and rapid onset of antimicrobial action. Mepilex Ag begins killing common pathogens found in wounds within 30 minutes and offers a sustained effect on pathogens for up to 7 days.
Safetac is a patented technology that offers atraumatic application and removal of the product. Dressings with Safetac technology not only minimize trauma to the wound, but prevent maceration by sealing around the surrounding skin of the wound. This unique combination of silver and Safetac technology offers clinicians antimicrobial effect while minimizing trauma and pain to the wound and the patient.
FDA approves carotid artery stenting system
Boston Scientific's NexStent Carotid Stent and Monorail Delivery System has been approved for use in patients with carotid artery disease who are at high risk for surgery. The new stent is manufactured by EndoTex Interventional Systems, Inc.
The NexStent Carotid Stent is a laser-cut, nitinol stent with a rolled sheet design that enables one stent size to adapt to varying vessel diameters and tapered or nontapered vessel configurations. Its self-sizing feature is designed to provide adaptability when treating lesions in the carotid artery, and its closed-cell configuration is designed to increase lesion coverage and provide a smooth inner lumen.
According to the company, the NexStent has been shown in studies to have excellent outcomes at 1 month through 1 year in patients with a wide range of lesions and vessel anatomy.
Expanded line of storage and transport items
EPS, Inc. has expanded its line of storage and transport items. In addition to totes, EPS, Inc. has added unit dose and medication exchange bins for the efficient handling of unit dose medication and I.V. bags; bulk supply tubs for large, unwieldy items; durable stock bins for transporting small products; autoclavable instrument trays for delicate instruments and supplies requiring special hand- ling; and mobile utility work-station carts to move both work areas and supplies at the same time. OR